Wu‐tong Ju

588 total citations
27 papers, 358 citations indexed

About

Wu‐tong Ju is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Wu‐tong Ju has authored 27 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Surgery and 10 papers in Otorhinolaryngology. Recurrent topics in Wu‐tong Ju's work include Head and Neck Cancer Studies (10 papers), Salivary Gland Tumors Diagnosis and Treatment (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Wu‐tong Ju is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Salivary Gland Tumors Diagnosis and Treatment (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Wu‐tong Ju collaborates with scholars based in China, United States and United Kingdom. Wu‐tong Ju's co-authors include Lai‐ping Zhong, Tongchao Zhao, Dongwang Zhu, Siyuan Liang, Zhihang Zhou, Minjun Dong, Jiang Li, Ying Liu, Lizhen Wang and Guopei Zhu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Clinical Nutrition.

In The Last Decade

Wu‐tong Ju

27 papers receiving 355 citations

Peers

Countries citing papers authored by Wu‐tong Ju

Since Specialization

Citations

This map shows the geographic impact of Wu‐tong Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu‐tong Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu‐tong Ju more than expected).

Fields of papers citing papers by Wu‐tong Ju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wu‐tong Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu‐tong Ju. The network helps show where Wu‐tong Ju may publish in the future.

Co-authorship network of co-authors of Wu‐tong Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Wu‐tong Ju. A scholar is included among the top collaborators of Wu‐tong Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wu‐tong Ju. Wu‐tong Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BGB-A317-212: A multicenter, open-label, phase II study to evaluate the efficacy and safety of tislelizumab in combination with lenvatinib in patients with selected solid tumors. 2024 ·Journal of Clinical Oncology ·(unknown), Zhisong He, Mingjun Zhang, Shusuan Jiang, (unknown), Feng Miao, Shenhong Qu, Wu‐tong Ju, Ke Wang, (unknown), Jifeng Feng	1
2	Associations of ctDNA clearance and pathological response after neoadjuvant treatment in patients with locally advanced oral cancer. 2024 ·Journal of Clinical Oncology ·Lai‐ping Zhong, Zhihang Zhou, (unknown), (unknown), Yi Lu, Bing Li, Jing Wang, Tongchao Zhao, Wu‐tong Ju, Dongwang Zhu	1
3	Can adjuvant radiotherapy be omitted for oral cavity cancer patients who received neoadjuvant therapy and surgery? A retrospective cohort study 2023 ·International Journal of Surgery ·Wu‐tong Ju, (unknown), Ying Liu, Jingjing Sun, Jiang Li, Minjun Dong, Qi Sun, Wentao Shi, Tongchao Zhao, Zhihang Zhou, (unknown), Xinyu Zhou, Dongwang Zhu, Shengjin Dou, Zhiyuan Zhang, Yue He, Chenping Zhang, Ronghui Xia, Guopei Zhu, Lai‐ping Zhong	2
4	Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial) 2023 ·International Journal of Surgery ·Yingying Huang, Jingjing Sun, (unknown), Dongwang Zhu, Minjun Dong, Shengjin Dou, Yong Tang, Wentao Shi, Qi Sun, Tongchao Zhao, Zhihang Zhou, Xinyu Zhou, Ying Liu, Li Jiang, Guopei Zhu, Ding Zhang, Yanan Chen, Qi Zhu, Wu‐tong Ju, Lai‐ping Zhong	39
5	A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma 2022 ·Nature Communications ·Wu‐tong Ju, Ronghui Xia, Dongwang Zhu, Shengjin Dou, Guopei Zhu, Minjun Dong, Lizhen Wang, Qi Sun, Tongchao Zhao, Zhihang Zhou, Siyuan Liang, Yingying Huang, Yong Tang, Sicheng Wu, Jing Xia, Shiqing Chen, Yuezong Bai, Jiang Li, Qi Zhu, Lai‐ping Zhong	78
6	Neoadjuvant Immunochemotherapy for Locally Advanced Resectable Oral Squamous Cell Carcinoma: A Prospective Single-Arm Trial 2022 ·SSRN Electronic Journal ·Yingying Huang, (unknown), Jun Li, Dongwang Zhu, Minjun Dong, Shengjin Dou, Yong Tang, Wentao Shi, Qi Sun, Tongchao Zhao, Zhihang Zhou, Xinyu Zhou, Ying Liu, Jiang Li, (unknown), Ding Zhang, Yanan Chen, Qi Zhu, Wu‐tong Ju, Lai‐ping Zhong	1
7	Neoadjuvant trial with toripalimab, albumin paclitaxel, and cisplatin on pathological response in locally advanced resectable oral squamous cell carcinoma (Illuminate Trial). 2022 ·Journal of Clinical Oncology ·Lai‐ping Zhong, Yingying Huang, (unknown), Jun Li, Minjun Dong, (unknown), Jiang Li, Wu‐tong Ju	3
8	Decreased Annexin A1 expression enhances sensitivity to docetaxel, cisplatin and 5‐fluorouracil combination induction chemotherapy in oral squamous cell carcinoma 2021 ·Journal of Oral Pathology and Medicine ·Wenwen Sun, Tongchao Zhao, Timothy Aladelusi, Wu‐tong Ju, Zhiyuan Zhang, Lai‐ping Zhong, Dongwang Zhu	3
9	Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo 2021 ·Translational Oncology ·Siyuan Liang, Tongchao Zhao, Zhihang Zhou, Wu‐tong Ju, Ying Liu, (unknown), Dongwang Zhu, Zhiyuan Zhang, Lai‐ping Zhong	18
10	Overcoming chemotherapy resistance using pH-sensitive hollow MnO2 nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma 2021 ·Journal of Nanobiotechnology ·Zhi-Hang Zhou, Siyuan Liang, Tongchao Zhao, Xuzhuo Chen, Xiankun Cao, Ming Qi, Yingying Huang, Wu‐tong Ju, Meng Yang, Dongwang Zhu, Yichuan Pang, Lai‐ping Zhong	47
11	High‐risk lymph node ratio predicts worse prognosis in patients with locally advanced oral cancer 2020 ·Journal of Oral Pathology and Medicine ·Tongchao Zhao, Siyuan Liang, Wu‐tong Ju, Yong Fu, Zhihang Zhou, Lizhen Wang, Li Jiang, Chenping Zhang, Zhiyuan Zhang, Lai‐ping Zhong	14
12	Normal BMI predicts the survival benefits of inductive docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced oral squamous cell carcinoma 2019 ·Clinical Nutrition ·Tongchao Zhao, Siyuan Liang, Wu‐tong Ju, Ying Liu, (unknown), Dongwang Zhu, Chenping Zhang, Zhiyuan Zhang, Lai‐ping Zhong	8
13	Clinical and pathologic analysis of myopericytoma in the oral and maxillofacial region 2019 ·Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ·Wu‐tong Ju, Tongchao Zhao, Ying Liu, Minjun Dong, Lizhen Wang, Jiang Li, (unknown), Lai‐ping Zhong	8
14	Computed tomographic features of adenoid cystic carcinoma in the palate 2019 ·Cancer Imaging ·Wu‐tong Ju, Tongchao Zhao, Ying Liu, (unknown), Minjun Dong, Qi Sun, Lizhen Wang, Jiang Li, Lai‐ping Zhong	7
15	Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma 2018 ·BMC Cancer ·Jie Ma, Yong Fu, (unknown), Ying Liu, (unknown), Wu‐tong Ju, Curtis R. Pickering, Jeffrey N. Myers, (unknown), (unknown)	22
16	Elevated growth differentiating factor 15 expression predicts long‑term benefit of docetaxel, cisplatin and 5‑fluorouracil induction chemotherapy in patients with oral cancer 2018 ·Oncology Letters ·Xiao Tang, Yongjie Hu, Wu‐tong Ju, Yong Fu, Wenwen Sun, Ying Liu, (unknown), Lizhen Wang, Li Jiang, (unknown), Chenping Zhang, Zhiyuan Zhang, Lai‐ping Zhong	9
17	Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI–TOF–MS Analysis 2018 ·PROTEOMICS - CLINICAL APPLICATIONS ·Ying Liu, (unknown), Wenwen Sun, Wu‐tong Ju, Yong Fu, (unknown), Jiang Li, (unknown), Zhiyuan Zhang, Lai‐ping Zhong	10
18	Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma 2017 ·Journal of Experimental & Clinical Cancer Research ·Hailong Ma, Shufang Jin, Wu‐tong Ju, Yong Fu, (unknown), Lizhen Wang, (unknown), Zhiyuan Zhang, Lai‐ping Zhong	31
19	Clinical and pathologic analyses of tuberculosis in the oral cavity: report of 11 cases 2017 ·Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ·Wu‐tong Ju, Yong Fu, Ying Liu, (unknown), Minjun Dong, Lizhen Wang, Jiang Li, Lai‐ping Zhong	13
20	Cutaneous Rosai-Dorfman Disease Recurrence in Infraorbital Region 2012 ·Journal of Craniofacial Surgery ·Liyan Lu, Wu‐tong Ju, Ming Cai, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact